UP
UroGen Pharma Ltd
🇺🇸XNAS.URGNUnited StatesHealthcare
$22.22USDup +0.69 (+3.2%)ClosedDelayed12:16 AM
Price$22.22+0.69 (+3.2%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- IL0011407140
- CUSIP
- M96088105
Company
- Employees
- 300
- Headquarters
- Princeton, United States
- Website
- https://www.urogen.com
- CEO
- Ms. Elizabeth A. Barrett
Market
- Shares outstanding
- 48.9M
- Market cap
- $1.08B
Key dates
- Next earnings
- Nov 5, 2026
Highlights
- Market cap
- $1.08B
- EPS LTM
- -$2.00calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -11.12calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $188.73M+100.27%up year on year
- Net income
- -$97.64M+37%up year on year
- Gross margin
- 90.85%+2.61%up year on year
- Free cash flow
- -$159.14M-28.83%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.